RDY announcements Dr. Reddy's Laboratories Ltd announcements and dividends declared NYSE
Dr. Reddy's Laboratories Ltd Complete list of announcements declared & dividend announcements by Dr. Reddy's Laboratories Ltd RDY
Dr. Reddy's Laboratories Ltd RDY listed on NYSE and deals in Health Care Major PharmaceuticalsAnnouncements and dividends declared by Dr. Reddy's Laboratories Ltd RDY
Dr Reddy's issues clarification after Congress alleges company benefited from Dhaval Buch connection, terms allegations 'baseless and malafide'
Dr Reddy's Laboratories has refuted allegations by the Indian National Congress that it benefited from its association with SEBI chairperson Madhabi Puri Buch's husband, Dhaval Buch. The company clarified that Dhaval Buch's engagement ended before Madhabi
Announcement as on 10 September 2024
Dr Reddy's gets USFDA's inspection report for Srikakulam-based API plant
Dr Reddy's Laboratories on Friday said it has received the establishment inspection report (EIR) from the US health regulator for its active pharmaceutical ingredient manufacturing facility (CTO-6) in Srikakulam, Andhra Pradesh. The US Food and Drug Admini
Announcement as on 06 September 2024
Dr Reddy's, Lupin recall products in US due to manufacturing issues
Dr Reddy's Laboratories and Lupin are recalling products in the US due to manufacturing issues, according to the USFDA. Dr Reddy's is recalling Ibuprofen tablets for failing impurity specifications, while Lupin is recalling Cefixime for Oral Suspension due
Announcement as on 04 September 2024
Dr Reddy's, Lupin recall products in US due to manufacturing issues: USFDA
Dr Reddy's Laboratories and Lupin are recalling products in the US due to manufacturing issues, as per the US Food and Drug Administration (USFDA). Dr Reddy's Laboratories Inc, a subsidiary of Hyderabad-based drug firm, is recalling Ibuprofen tablets in mu
Announcement as on 04 September 2024
Dr Reddy's gets establishment inspection report from USFDA for Visakhapatnam units
Dr Reddy's Laboratories Ltd has obtained an Establishment Inspection Report from the USFDA for its Duvvada units, now classified as Voluntary Action Indicated. The units underwent an inspection from May 8 to May 17, 2024, which led to a Form 483 with obser
Announcement as on 12 August 2024
Announcements by Dr. Reddy's Laboratories Ltd first page | Next page | Prev page |
RDY Dr. Reddy's Laboratories Ltd current price & indicator signals
Recent prices of RDY Dr. Reddy's Laboratories Ltd are as follows: Daily volume is divided by 10 day averaged volume
| Date | Close | Range | Change % | Volume |
| 27 Mon Apr 2026 | 13.97 | 13.85 to 14.05 | 2.19% | 0.62 times |
| 24 Fri Apr 2026 | 13.67 | 13.57 to 13.83 | 0.66% | 0.95 times |
| 23 Thu Apr 2026 | 13.58 | 13.33 to 13.83 | 5.76% | 2.81 times |
| 22 Wed Apr 2026 | 12.84 | 12.81 to 13.04 | 0.55% | 1.06 times |
| 21 Tue Apr 2026 | 12.77 | 12.77 to 13.03 | -2.44% | 0.97 times |
| 20 Mon Apr 2026 | 13.09 | 13.05 to 13.17 | -1.58% | 0.65 times |
| 17 Fri Apr 2026 | 13.30 | 13.29 to 13.59 | 1.84% | 0.69 times |
| 16 Thu Apr 2026 | 13.06 | 12.97 to 13.13 | 0.93% | 0.62 times |
| 15 Wed Apr 2026 | 12.94 | 12.86 to 13.36 | -1.45% | 0.84 times |
| 14 Tue Apr 2026 | 13.13 | 13.12 to 13.37 | -1.06% | 0.81 times |
| 13 Mon Apr 2026 | 13.27 | 13.10 to 13.29 | -0.3% | 0.61 times |
| 10 Fri Apr 2026 | 13.31 | 13.31 to 13.60 | 0.38% | 0.59 times |
Videos related to: RDY announcements Dr. Reddy's Laboratories Ltd announcements and dividends declared NYSE
Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra
Hindi Video What Is Needed To Succeed In Stock Markets
- NYSE Screeners
- NYSE Daily Screener
- NYSE Weekly Screener
- NYSE Monthly Screener
- Support & Resistance
- NYSE Shares Near Support
- NYSE Shares Near Resistance


